Altimmune Inc (ALT)
7.61
-0.84
(-9.99%)
USD |
NASDAQ |
Nov 15, 16:00
7.57
-0.04
(-0.53%)
After-Hours: 20:00
Altimmune Shares Outstanding: 71.07M for Aug. 2, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
August 02, 2024 | 71.07M |
June 30, 2024 | 71.05M |
May 03, 2024 | 70.90M |
March 31, 2024 | 70.90M |
March 22, 2024 | 70.90M |
December 31, 2023 | 70.68M |
November 03, 2023 | 53.73M |
September 30, 2023 | 52.86M |
August 11, 2023 | 52.69M |
August 04, 2023 | 52.69M |
August 01, 2023 | 52.69M |
June 30, 2023 | 52.66M |
May 05, 2023 | 49.29M |
March 31, 2023 | 49.29M |
February 24, 2023 | 49.28M |
December 31, 2022 | 49.20M |
November 04, 2022 | 49.16M |
September 30, 2022 | 49.16M |
August 12, 2022 | 49.03M |
August 05, 2022 | 48.54M |
August 01, 2022 | 48.15M |
June 30, 2022 | 46.37M |
May 10, 2022 | 43.22M |
March 31, 2022 | 43.22M |
March 11, 2022 | 43.22M |
Date | Value |
---|---|
December 31, 2021 | 40.99M |
November 05, 2021 | 39.74M |
September 30, 2021 | 39.70M |
August 10, 2021 | 39.71M |
August 06, 2021 | 39.71M |
August 01, 2021 | 39.71M |
June 30, 2021 | 39.69M |
May 14, 2021 | 38.40M |
March 31, 2021 | 38.26M |
February 23, 2021 | 37.15M |
January 11, 2021 | 37.14M |
December 31, 2020 | 37.14M |
November 06, 2020 | 33.07M |
September 30, 2020 | 33.07M |
August 20, 2020 | 32.91M |
August 10, 2020 | 32.91M |
August 07, 2020 | 32.90M |
August 01, 2020 | 32.89M |
July 16, 2020 | 32.00M |
July 10, 2020 | 27.88M |
June 30, 2020 | 26.55M |
June 15, 2020 | 21.61M |
May 29, 2020 | 20.11M |
May 13, 2020 | 15.53M |
March 31, 2020 | 15.36M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
15.31M
Minimum
Dec 31 2019
71.07M
Maximum
Aug 02 2024
42.59M
Average
40.37M
Median
Shares Outstanding Benchmarks
Eli Lilly and Co | 949.32M |
Viking Therapeutics Inc | 111.44M |
Amgen Inc | 537.53M |
Avid Bioservices Inc | 63.80M |
NovaBay Pharmaceuticals Inc | 4.886M |